These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3248518)

  • 21. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PCI for totally occluded site consisting of huge thrombus.
    Oyama N; Urasawa K; Sakai H; Kitabatake A
    J Invasive Cardiol; 2003 Oct; 15(10):603-6. PubMed ID: 14519898
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic effect of defibrase in chronic glomerulonephritis with chronic renal failure].
    Wu JF; Wang SH
    Zhonghua Nei Ke Za Zhi; 1989 Mar; 28(3):171-3, 188. PubMed ID: 2805953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of urokinase used in combination with batroxobin (DF-521) in rat model of focal cerebral ischemia-reperfusion].
    Hu XS; Zhou D; Hu XY; Zhang YZ; Tian LY; Huang J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):395-7. PubMed ID: 15181847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue-type plasminogen activator for acute coronary thrombosis. The Medical Letter.
    Conn Med; 1988 Feb; 52(2):105-6. PubMed ID: 3126023
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intracoronary thrombolysis using urokinase in acute myocardial infarct].
    Kanmatsuse K; Kajwara N; Onikura S; Satoh K; Toda Y
    Ter Arkh; 1982; 54(11):25-7. PubMed ID: 6760435
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
    Shebuski RJ; Smith JM; Storer BL; Granett JR; Bugelski PJ
    J Pharmacol Exp Ther; 1988 Aug; 246(2):790-6. PubMed ID: 3136245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombolytic therapy in acute myocardial infarction.
    Smucker DR; Burket MW
    Am Fam Physician; 1988 May; 37(5):265-74. PubMed ID: 3129924
    [No Abstract]   [Full Text] [Related]  

  • 29. Tissue plasminogen activator for coronary thrombosis.
    DiPalma JR
    Am Fam Physician; 1988 Mar; 37(3):291-5. PubMed ID: 3126630
    [No Abstract]   [Full Text] [Related]  

  • 30. [Superiority of defibrinase over heparin in the treatment of acute attacks of cor pulmonale. A comparative study].
    Gao MZ; Liu FQ; Zhu LX
    Zhonghua Nei Ke Za Zhi; 1988 Jul; 27(7):419-22, 454. PubMed ID: 3219947
    [No Abstract]   [Full Text] [Related]  

  • 31. Urokinase in thrombotic coronary occlusion.
    O'Rourke M
    Med J Aust; 1989 Dec 4-18; 151(11-12):726. PubMed ID: 2593933
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of defibrinogenation and steroid therapies on sudden deafness.
    Kubo T; Matsunaga T; Asai H; Kawamoto K; Kusakari J; Nomura Y; Oda M; Yanagita N; Niwa H; Uemura T
    Arch Otolaryngol Head Neck Surg; 1988 Jun; 114(6):649-52. PubMed ID: 3284549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of batroxobin levels in the plasma of guinea pigs after epicutaneous and intravenous applications.
    Meier J; Adler C; Weiss N
    Toxicon; 1988; 26(10):964-6. PubMed ID: 3059582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac failure responding to growth hormone.
    Cuneo RC; Wilmshurst P; Lowy C; McGauley G; Sönksen PH
    Lancet; 1989 Apr; 1(8642):838-9. PubMed ID: 2564917
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental coronary thrombosis in the dog; description of a method.
    GAGE AA; OLSON KC; CHARDACK WM
    Ann Surg; 1956 Apr; 143(4):535-43. PubMed ID: 13303093
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparison of the efficacy of intravenous urokinase and defibrase on 6-hour-old canine coronary thrombosis].
    Huang DX; Song AL; Yang XS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Dec; 16(6):363-5, 384. PubMed ID: 3248518
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the thrombolytic efficacy of defibrase and urokinase on canine coronary artery thrombosis and the mechanism of urokinase-induced hemorrhage.
    Huang DX; Song A; Yang X; Wang S
    Acta Cardiol; 1987; 42(4):249-61. PubMed ID: 3499037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of intracoronary or intravenous urokinase on canine coronary thrombosis].
    Song AL
    Zhonghua Yi Xue Za Zhi; 1987 Dec; 67(12):668-70. PubMed ID: 3130159
    [No Abstract]   [Full Text] [Related]  

  • 39. Preventive effects of batroxobin on experimental canine coronary thrombosis.
    Tomaru T; Uchida Y; Sonoki H; Sugimoto T
    Clin Cardiol; 1988 Apr; 11(4):223-30. PubMed ID: 3163298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathophysiology and treatment of thrombosis. 3. Prevention and treatment of thrombosis. (1) The role of intracoronary thrombi, platelet function and prostaglandins in the pathogenesis of myocardial infarction; with special reference to intracoronary thrombolysis treatment].
    Kawai C; Yui Y
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):43-8. PubMed ID: 3553380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.